Pramlintide Antagonizes Beta Amyloid (Aβ)- and Human Amylin-Induced Depression of Hippocampal Long-Term Potentiation

Molecular Neurobiology
Ryoichi KimuraJack H Jhamandas

Abstract

Accumulation of amyloid-β peptide (Aβ) is a pathological hallmark of Alzheimer's disease (AD). We have previously demonstrated that electrophysiological and neurotoxic effects of Aβ and human amylin are expressed via the amylin receptor. Recently, pramlintide, a synthetic analog of amylin, has been reported to improve cognitive function in transgenic AD mouse models. In this study, we examined the effects of pramlintide on Aβ1-42 and human amylin-evoked depression of long-term potentiation (LTP) at Schaeffer collateral-CA1 hippocampal synapses. In mouse hippocampal brain slices, field excitatory postsynaptic potentials (fEPSPs) were recorded from the stratum radiatum layer of the CA1 area in response to electrical stimulation of Schaeffer collateral afferents and LTP induced by 3-theta-burst stimulation (TBS) protocol. Aβ1-42 (50 nM) and human amylin (50 nM), but not Aβ42-1 (50 nM), depressed LTP. Pre-application of pramlintide (250 nM) blocked Aβ- and human amylin-induced reduction of LTP without affecting baseline transmission or LTP. We also examined the effects of pramlintide on LTP in transgenic mice (TgCRND8) that over-express amyloid precursor protein. In contrast to wild-type controls, where robust LTP was observed, 10-...Continue Reading

References

Jan 1, 1994·Annual Review of Neuroscience·D J Selkoe
Apr 29, 1997·Proceedings of the National Academy of Sciences of the United States of America·S DoréR Quirion
Feb 24, 2001·Annals of the New York Academy of Sciences·D L PriceD R Borchelt
Jun 12, 2002·The Journal of Biological Chemistry·Karie N DahlgrenMary Jo LaDu
Dec 25, 2002·The Journal of Biological Chemistry·W Blaine StineMary Jo LaDu
Jun 18, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Jack H Jhamandas, David MacTavish
Feb 24, 2006·Advances in Pharmacology·Andrew Young
Apr 7, 2007·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Giuseppina CantarellaGiuseppe Clementi
Nov 28, 2007·Annual Review of Pathology·Daniel M SkovronskyJohn Q Trojanowski
May 22, 2009·Journal of Neurochemistry·John Hardy
Jan 29, 2010·The New England Journal of Medicine·Henry W Querfurth, Frank M LaFerla
Jan 13, 2011·The American Journal of Pathology·Jack H JhamandasDavid MacTavish
Sep 29, 2011·Apoptosis : an International Journal on Programmed Cell Death·Jack H Jhamandas, David Mactavish
Dec 1, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Ryoichi KimuraJack H Jhamandas

❮ Previous
Next ❯

Citations

Aug 21, 2019·Journal of Molecular Modeling·Nelson A AlvesRafael B Frigori
Oct 8, 2017·Journal of Neuroinflammation·Wen FuJack Jhamandas
Oct 5, 2018·Journal of Alzheimer's Disease : JAD·John GrizzantiGemma Casadesus
Dec 14, 2017·Neuropharmacology·Elizabeth G Mietlicki-Baase

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.